Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 to 75				Other				KMU-IRB00003151 VGHKS95-CT3-11, NCT00656968


2.		Nexium Study To Suppress Nausea During Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				H-16348 Nexium Study, NCT00206440

Last Modified: 5/15/2008 First Published: 7/23/2006


3.		Phase III Randomized Chemoprevention Study of Esomeprazole With Versus Without Acetylsalicyclic Acid (Aspirin) in Preventing Esophageal Cancer in Patients With Barrett's Metaplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Prevention				Active				18 and over				Other, Pharmaceutical / Industry				OCTO-ASPECT RADCLIFFE-32, ZENECA-RADCLIFFE-32, EUDRACT-2004-003836-77, ISRCTN85156844, EU-20628, NCT00357682

Last Modified: 6/12/2008 First Published: 5/11/2007


4.		Phase II Randomized Chemoprevention Study of Esomeprazole Magnesium With Versus Without Acetylsalicylic Acid (Aspirin) in Patients With Barrett Esophagus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Prevention				Active				18 and over				NCI				MAYO-MAY04-4-01 MAY04-4-01, NCT00474903


5.		APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				18 and over				Other				D9612L00088 NCT00546065


6.		Evaluation of Esomeprazole in Treating Gastro-Esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				18 and over				Other				200308067 NCT00222079

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute